Weight Loss Clinical Trials in Houston, TX

11 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	<1 mi
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes	Phase 2	Eli Lilly and Company	<1 mi
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity	N/A	The Methodist Hospital Research Institute	<1 mi
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus	Phase 2	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	<1 mi
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass	N/A	Boston Scientific Corporation	<1 mi
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study	Early 1	M.D. Anderson Cancer Center	<1 mi
A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance	Phase 4	AbbVie	7 mi
Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss	—	Boston Scientific Corporation	7 mi
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy	Phase 2	Endevica Bio	23 mi
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia	Phase 1	AVEO Pharmaceuticals, Inc.	23 mi
The Metabolic and Genetic Drivers of Body Composition Changes Following Weight Loss Surgery	—	The University of Texas Medical Branch, Galveston	47 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.